ARTICLE | Clinical News
PTIE to begin Phase II
January 18, 2002 8:00 AM UTC
Pain Therapeutics (PTIE) will begin this quarter a U.K. Phase II trial of PTI-801, an immediate release formulation of oxycodone combined with low dose naltrexone for chronic pain. ...